Kymera Therapeutics, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2025
Total Assets: $1.74B
Liabilities Breakdown FY2025
Total Liabilities: $163.1M
Asset Breakdown
Total Assets: $1.74B
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $357.0M | 20.5% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $43.2M | 2.5% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $1.34B | 77.0% |
Liabilities Breakdown
Total Liabilities: $163.1M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $4.0M | 2.5% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $159.1M | 97.5% |